Bed Bath & Beyond, AMC and more

Image of an AMC theater amid the coronavirus (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., January 27, 2021.

Carlo Allegri | Reuters

Check out the companies that make headlines in midday trading.

Outdoor shower bed, AMC – Stocks rose 39.8% and 8% respectively when social media traders appeared invest in two stocks memeeven without an obvious catalyst.

Health signal – Shares rose 11% after Wall Street Journal reportciting people familiar with the matter, that CVS Health is planning to bid for the home health services company.

The first solar energy – First Solar rose 4.8% after Goldman Sachs upgrade stock to overload neutral word. The bank said solar tech stock would benefit from the passage of the Inflation Reduction Act and raise its price target to $126 from $83 a share.

Rhythm Pharmaceuticals – Biopharma stock up 4.4% after Goldman Sachs upgrade it to buy from neutralshares could rise about 40% after a successful trial of an obesity drug.

Golden Barrick Miners rose 3.9% after beating analysts’ expectations in second-quarter results due to higher copper production.

Palantir Technologies Shares of Palantir fell more than 14.2% after the software company known for doing business with the government reported a 1% loss per share in its most recent quarter. According to Refinitiv, analysts were expecting earnings of 3 cents per share. Chief Financial Officer David Glazer told CNBC that the company’s failure was due to a drop in investments and stock markets.

Tyson Foods – Shares of the food products company fell 8.4% after Tyson missed earnings estimates for its fiscal third quarter. Company executives said in an investor call that supply chain issues were affecting their ability to fulfill customer orders, according to a transcript of the call from FactSet .

Nvidia – Semiconductor shares fell 6.3% after Nvidia reported a drop in revenue for the second quarter. The chipmaker generated $6.7 billion in revenue, compared with analyst expectations of $8.1 billion, citing weak gaming.

BioNTech – The German biotech company, which works with Pfizer on a Covid-19 vaccine, fell 7.5% after it reported earnings and revenue that fell short of expectations. The company said its variant-tuned Covid-19 vaccine will provide increased demand in the fourth quarter.

– CNBC’s Tanaya Macheel, Jesse Pound, Samantha Subin, and Michelle Fox Theobald contributed reporting

Source link


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button